Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancer

Breast

Volumn 15, Issue 1, 2006, Pages 64-68

  Fürstenberger, Gregor ^a   Senn, Eva ^a   Morant, Rudolf ^a   Bolliger, Barbara ^a   Senn, Hans Jörg ^a  

^a Tumor Center ZeTuP   (Switzerland)

Author keywords

Anthracyclines; Breast neoplasms; Drug therapy; Insulin like growth factor binding protein 3; Insulin like growth factor 1; Serum

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

EID: 32244434768     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.04.009     Document Type: Article

References (36)

1. M.N. Pollak E.S. Schernhammer S.E. Hankinson Insulin-like growth factors and neoplasia Nat Rev Cancer 4 2004 505-518
2. G. Fürstenberger H.J. Senn Insulin-like growth factors and cancer Lancet Oncol 3 2002 298-302
3. D. LeRoith C.T. Roberts Jr The insulin-like growth factor system and cancer Cancer Lett 195 2 2003 127-137
4. G. Fürstenberger M. Morant H.J. Senn Insulin-like growth factors and breast cancer Onkologie 26 2003 290-294
5. S. Rajaram D.J. Baylink S. Mohan Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions Endocr Rev 18 1997 801-831
6. L. Sepp-Lorenzino Structure and function of the insulin-like growth factor I receptor Breast Cancer Res Treat 47 1998 235-253
7. A.J. Oates L.M. Schumaker S.B. Jenkins et al. The mannose 6-phosphate/ insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene Breast Cancer Res Treat 47 1998 269-281
8. D.R. Clemmons Insulin-like growth factor binding proteins and their role in controlling IGF actions Cytokine Growth Factor Rev 8 1997 45-62
9. W.I. Wood G. Cachianes W.J. Henzel et al. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein Mol Endocrinol 2 1988 1176-1185
10. S.R. Leong R.C. Baxter T. Camerato J. Dai W.I. Wood Structure and functional expression of the acid-labile subunit of the insulin-like growth factor-binding protein complex Mol Endocrinol 6 1992 870-876
11. H. Yu J. Mistry M.J. Nicar et al. Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation J Clin Lab Anal 13 1999 166-172
12. A. Grimberg P. Cohen Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis J Cell Physiol 183 2000 1-9
13. E. Chin J. Zhou J. Dai R.C. Baxter C.A. Bondy Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex Endocrinology 134 1994 2498-2504
14. H. Olivecrona A. Hilding C. Ekstrom et al. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: Serum levels and hepatic messenger ribonucleic acid responses in humans J Clin Endocrinol Metab 84 1999 553-560
15. R.C. Baxter J.L. Martin Binding proteins for the insulin-like growth factors: Structure, regulation and function Prog Growth Factor Res 1 1989 49-68
16. M. Karas M. Danilenko D. Fishman D. LeRoith J. Levy Y. Sharoni Membrane-associated insulin-like growth factor-binding protein-3 inhibits insulin-like growth factor-I-induced insulin-like growth factor-I receptor signaling in ishikawa endometrial cancer cells J Biol Chem 272 1997 16514-16520
17. C.A. Conover D.R. Powell Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-I-induced receptor down-regulation and cell desensitization in cultured bovine fibroblasts Endocrinology 129 1991 710-716
18. S.E. Hankinson W.C. Willett G.A. Colditz et al. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer Lancet 351 1998 1393-1396
19. C.S. Mantzoros A. Tzonon L.B. Signorello M. Stampfer D. Trichopoulos H.O. Adami Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia Br J Cancer 76 1997 1115-1118
20. J.M. Chan M.J. Stampfer E. Giovannucci et al. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study Science 279 1998 563-566
21. J. Ma M.N. Pollak E. Giovannucci et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3 J Natl Cancer Inst 91 1999 620-625
22. H. Yu M.R. Spitz J. Mistry J. Gu W.K. Hong X. Wu Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control study J Natl Cancer Inst 91 1999 151-156
23. S.I. Helle J.M. Holly M. Tally K. Hall J. Vander Stappen P.E. Lonning Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patients Int J Cancer 69 1996 335-339
24. M. Pollak J. Costantino C. Polychronakos et al. Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients J Natl Cancer Inst 82 1990 1693-1697
25. J.B. Lawrence C.A. Conover T.C. Haddad et al. Evaluation of continuous infusion suramin in metastatic breast cancer: Impact on plasma levels of insulin-like growth factors (IGFs) and IGF binding proteins Clin Cancer Res 3 1997 1713-1720
26. A. Decensi H. Johansson R. Miceli et al. Long-term effect of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in woman with early breast cancer Cancer Epidemiol Biomarkers Prev 10 2001 1047-1053
27. L. Ferrari A. Martinetti N. Zilembo et al. Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients J Steroid Biochem Mol Biol 80 2002 411-418
28. E. Bajetta L. Ferrari L. Celio et al. The aromatase inhibitor letrozole in advanced breast cancer: Effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels J Steroid Biochem Mol Biol 63 1997 261-267
29. E.A. Lien D.C. Johannessen A. Aakvaag P.E. Lonning Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients J Steroid Biochem Mol Biol 41 1992 541-543
30. L. Ferrari N. Zilembo E. Bajetta et al. Effect of two-4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer Breast Cancer Res Treat 30 1994 127-132
31. D. Kajdaniuk B. Marek Influence of adjuvant chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil on plasma insulin-like growth factor-I and chosen hormones in breast cancer pre-menopausal patients J Clin Pharm Ther 25 2000 67-72
32. J.P. Peyrat F. Revillion J. Bonneterre Plasma insulin-like growth factor in primary breast cancer patients treated with adjuvant chemotherapy Br J Cancer 77 1998 1669-1671
33. I.M. Holdaway B.H. Mason A.E. Lethaby V. Singh V.J. Harvey P.I. Thompson B.D. Evans Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer ANZ J Surg 73 2003 905-908
34. C.T. Roberts Jr A.L. Brown D.E. Graham et al. Growth hormone regulates the abundance of insulin-like growth factor I RNA in adult rat liver J Biol Chem 261 1986 10025-10028
35. T. Kalme M. Loukovaara H. Koistinen R. Koistinen M. Seppala P. Leinonen Factors regulating insulin-like growth factor binding protein-3 secretion from human hepatoma (HepG2) cells Steroid Biochem Mol Biol 78 2001 131-135
36. S.I. Helle S. Geisler T. Aas T. Paulsen J.M. Holly P.E. Lonning Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer Br J Cancer 85 2001 74-77